Biotechnology, pharmaceutical, CMO, and preclinical CRO companies are currently undergoing a phase of turmoil due to safety, security, and compliance related challenges that often hinder the efficiency of their laboratory operations. In the absence of domain-specific software addressing the necessities of global research and analytical laboratories, many resort to insecure, non-scalable, non-robust solutions. Many enterprises even waste significant funds on building their own software, resulting in highly inefficient outcomes. BioRAFT, is successfully mitigating these challenges and redefining safety and compliance management for research laboratories. The Cambridge, MA-based company meets the industry’s requirements with an integrated, secure, and easy to use laboratory safety, compliance, and training software designed by researchers, for researchers.
The challenge for most research organizations is their inefficient internal processes and a shortage of staff for EHS, security, and compliance management for their research laboratories. This ultimately results in mainstream researchers getting burdened with tedious, time consuming administrative obligations that waste time and distract them from their key responsibilities, which is to do breakthrough research. “With BioRAFT, researchers and EHS administrators get access to all safety and compliance systems and reporting under one centralized research management platform, which enables them to focus more on their core research without time lags and hassle,” explains Nathan Watson, CEO and President, BioRAFT.
The centralized solution comprises several modules that have been built as per research enterprises’ needs and seamlessly integrates into their systems.
BioRAFT’s unique platform coupled with its customer-centric approach has enabled the company to transcend from a traditional solutions provider into a trusted global partner
These modules include assessments, laboratory and facility inspections, hazard-based training and communication, equipment tracking, biological and chemical safety, radioisotope management, documentation, and reporting. These are also integrated with the clients’ single sign-on, user directories, HR systems, and health and safety training programs. The research management platform consolidates and analyzes data from the research enterprises’ systems and builds a centralized repository to enable a real-time view of the organizations’ compliance and safety standards. With an easy-to-use interface, intuitive dashboards and streamlined workflows, the solution assists researchers and safety professionals enables safe and secure research progress without unwanted hassles in EHS and compliance management. Watson also points out that with a highly scalable platform, they can add new modules on top of the existing software platform infrastructure by collaborating with life science organizations to address their specific pain points.
In one of its projects, the company assisted a global client that was facing major process compliance and efficiency challenges with their array of piecemeal tools, spreadsheets, and self-built solutions. BioRAFT assisted the company to migrate onto BioRAFT’s all-in-one platform. It allowed the company to manage processes efficiently with a small global EHS team and kept their research operations cost-effective and well organized. This helped the client to attain rapid and safe global expansion through standardization in BioRAFT.
BioRAFT’s unique platform coupled with its customer-centric approach has enabled the company to transcend traditional solutions providers and become a trusted global partner. Having recently acquired ChemTracker, the company continues to build more robust and quality enterprise-grade applications for laboratory safety around the globe. “Life science companies no longer need to rely on piecemeal or self-developed solutions. We have a comprehensive system that is off the shelf ready, highly secure, and addresses exactly what they need to achieve compliance, mitigate risk, and keep costs controlled,” concludes Watson.